Skip to Content
Merck
All Photos(2)

Documents

A8327

Sigma-Aldrich

Bovine Serum Albumin solution

30%±2% in 0.85% sodium chloride, aseptically filled

Synonym(s):

Albumin solution from bovine serum, BSA solution

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

CAS Number:
9048-46-8
MDL number:
MFCD00130384
UNSPSC Code:
12352202
NACRES:
NA.27

biological source

bovine

Quality Level

300

sterility

aseptically filled

Assay

28-32% protein basis (biuret)

form

solution

purified by

heat shock fractionation

does not contain

stabilizer or preservative

origin

USA origin

concentration

28-32% protein (biuret)
30%±2% in 0.85% sodium chloride

technique(s)

ELISA: suitable

UniProt accession no.

P02769

storage temp.

2-8°C

Gene Information

bovine ... ALB(280717)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Serum Albumin is a protein widely present in the circulating blood. Albumin has a helical structure with three domains that form a heart-like shape. It belongs to the four-member albumin superfamily.

Application

Bovine Serum Albumin solution has been used:
  • as one of the experimental components to resemble the plasma-protein-rich acute respiratory distress syndrome (ARDS) edema liquid
  • to prepare embryos for fluorescent staining of the actin cytoskeleton
  • in tissue culture and neurite outgrowth assay

Biochem/physiol Actions

Serum Albumin regulates the osmotic pressure and pH of the blood. It transports various endogenous and exogenous compounds such as amino acids, drugs, steroids, and fatty acids. Bovine serum albumin (BSA) serves as a molecular weight standard, standard in vaccine preparation, and enzyme-linked immunosorbent assay (ELISA).

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000389069
SLCR6336
0000377326
SLCP9457
0000376371

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

André G Costa-Martins et al.
Cell reports. Medicine, 2(12), 100465-100465 (2022-01-15)
In children lacking influenza-specific adaptive immunity, upper respiratory tract innate immune responses may influence viral replication and disease outcome. We use trivalent live attenuated influenza vaccine (LAIV) as a surrogate challenge model in children aged 24-59 months to identify pre-infection mucosal
Kushal Suryamohan et al.
Communications biology, 4(1), 475-475 (2021-04-14)
COVID-19 is a respiratory illness caused by a novel coronavirus called SARS-CoV-2. The viral spike (S) protein engages the human angiotensin-converting enzyme 2 (ACE2) receptor to invade host cells with ~10-15-fold higher affinity compared to SARS-CoV S-protein, making it highly
Ping Yang et al.
Acta pharmacologica Sinica, 31(5), 531-539 (2010-04-13)
To investigate whether lentiviral vector (LV)-mediated expression of a dominant negative mutant Rho-kinase (DNROCK) could inhibit activation of the Rho/ROCK signaling pathway and promote neurite outgrowth in a hostile microenvironment mimicking the injured central nervous system (CNS) in vitro. Lentiviral
Umma Habiba et al.
Oncology letters, 13(1), 321-328 (2017-01-27)
Oral leukoplakia (OL) is a clinically diagnosed preneoplastic lesion of the oral cavity with an increased oral cancer risk. However, the risk of malignant transformation is still difficult to assess. The objective of the present study was to examine the
M Gordon Joyce et al.
Cell reports, 37(12), 110143-110143 (2021-12-18)
The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-generation vaccines has been highlighted by the rise of variants of concern (VoCs) and the long-term threat of emerging coronaviruses. Here, we design and characterize four categories of engineered nanoparticle
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service